Elchalal U, Hagay Z, Manor M, Landau Z, Shachbari A
Department of Obstetrics and Gynecology, Kaplan Hospital, Rehovot, Israel.
Isr J Med Sci. 1993 Jun-Jul;29(6-7):385-7.
Plasmodium falciparum malaria is infrequently recognized in Israel as a cause of infection during pregnancy. We expect that with increasing frequency physicians in Israel will confront patients with malaria. Special concern should be given to malaria in pregnancy because of its serious complications. Thus, prompt diagnosis and treatment are essential. While chloroquine is safe for use in pregnancy, drug resistance is common, especially with Plasmodium falciparum. There is concern about the safety of other antimalarial agents during pregnancy. We recently observed a case of chloroquine-resistant Plasmodium falciparum malaria during pregnancy in a new immigrant primigravida from Ethiopia. Malaria in patients from endemic regions is less severe than in nonimmune hosts. Therefore, we elected to follow the patient's parasitemia periodically without additional antimalarial treatment until after delivery.
在以色列,恶性疟原虫疟疾作为孕期感染病因鲜为人知。我们预计,随着频率增加,以色列的医生将会遇到患疟疾的患者。鉴于疟疾的严重并发症,孕期疟疾应予以特别关注。因此,迅速诊断和治疗至关重要。虽然氯喹在孕期使用是安全的,但耐药情况常见,尤其是对恶性疟原虫。人们担心其他抗疟药在孕期的安全性。我们最近观察到一名来自埃塞俄比亚的初孕新移民在孕期患氯喹耐药性恶性疟原虫疟疾。来自流行地区患者的疟疾不如非免疫宿主严重。因此,我们选择定期监测患者的寄生虫血症,在分娩前不进行额外抗疟治疗。